The Institute for Quality and Efficiency in Healthcare (IQWiG) (German: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesenis) is a German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions (e.g. surgical procedures), diagnostic and screening methods, and treatment and disease management. IQWiG also supplies health information to patients and the general community. The organization is independent of the pharmaceuticals industry, contracted solely by the Federal Ministry of Health and the Joint Federal Committee. IQWiG was founded in 2004 under the directorship of Dr Peter Sawicki, who was in September 2010 replaced by Dr Jürgen Windeler. Its deputy director is Dr Stefan Lange. IQWiG is divided into the following departments, which publish reports: General health information, written in plain language, is additionally produced by a Health Information department. These departments are also supported by Administration and Communication departments.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Dasabuvir (trade name Exviera) and the fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) have been available since January 2015 for the treatment of adults with chronic hepatitis C infection. ...
Aug 6, 2015
0
9
An early benefit assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in 2020 already addressed the question of whether daratumumab in combination with lenalidomide and dexamethasone ...
Jan 4, 2022
0
14
With the help of a mandibular advancement device (MAD), daytime sleepiness of patients with obstructive sleep apnoea can be relieved. Treatment with an MAD is not inferior to positive airway pressure (PAP) therapy with a ...
Jun 3, 2020
0
0
The drug combination of ledipasvir and sofosbuvir (trade name Harvoni) has been available since November 2014 for the treatment of chronic hepatitis C infection. The German Institute for Quality and Efficiency in Health Care ...
Mar 9, 2015
0
7
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated the advantages and disadvantages of different treatments of inflammatory disease of the periodontium. The final report is now available. ...
Apr 30, 2018
0
2
Romosozumab is a bone-forming monoclonal antibody used in women after menopause for the treatment of severe osteoporosis if there is a high risk of bone fractures. Having been granted approval for this therapeutic indication ...
Jun 15, 2020
0
1
Daclatasvir (trade name Daklinza) has been approved since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. According to the dossier assessment conducted by the German Institute for Quality ...
Feb 24, 2015
0
18
The fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) has been available since January 2015 for the treatment of adults with chronic hepatitis C infection. The German Institute for Quality ...
May 28, 2015
0
8
Patients with a history of coronary heart disease (CHD) or acute coronary syndrome (ACS) benefit more from treatment with a statin in combination with ezetimibe than from treatment with a statin alone. However, there is no ...
Aug 8, 2019
0
3
In a series of commissions awarded by the Federal Joint Committee (G-BA) to the Institute for Quality and Efficiency in Health Care (IQWiG), the question is whether for certain surgical procedures, a correlation can be shown ...
Dec 28, 2020
0
2
